hepatitis guide

Navigation options for

hepatitis

Hepatitis

Additional Resources

The Unspecific Character Of Hepatitis C Symptoms

Hepatitis C generally refers to infection of the liver. The disease has an incubation stage of up to six months, and patients often have no clear symptoms over this period of time. In some cases Read more...

Hepatitis

The Five Hepatitis Types

Hepatitis is an inflammation of the liver. is usually caused by viruses, but bacteria can also be a cause of hepatitis. Current studies conducted by scientists have shown that there are no more than five viruses that can cause hepatitis. All these types of are very serious and they can do a lot of damage to your liver. The five types of are A, B, C, D and E.

Hepatitis A is caused by a virus that spreads through water or food. The A virus is found in one’s fecal materials. If somehow, this material contaminates water of food, the virus is then spread very easily. The symptoms for this type of are very similar to those of the flu. If you have A, vomiting, nausea, fatigue and abdominal pain will be some of the

symptoms. Furthermore, if your urine is dark or your skin and eyes turn yellowish, then you can definitely say that you have hepatitis. In this case, a doctor should be seen right away. He/ she will do some further tests to see if indeed you have A or not. If you have hepatitis, then you will start a treatment. In cases of A, the best treatment there is to get plenty of rest and stay away from sexual contact. A can last somewhere between two weeks and half a year. There are currently two vaccines available for A. One of the vaccines is for those that have already been exposed to the virus and the second one are to prevent A.

The second type of hepatitis: B spreads through blood and sexual contact. B has almost the same symptoms as A. Loss of appetite can also be another symptom. There are people that can have B and still have no symptoms at all. The treatment for this type of is with medication. For children, vaccines are also available against hepatitis.

Hepatitis C, like B is also spread by contact with blood that has been contaminated. In this case of hepatitis, more than half of the patients have no symptoms at all. Those who have signs of feel a loss of appetite, nausea, fatigue and jaundice. For this particular type of there is no vaccine. Treatment for C is with interferon or some combinations using this drug.

Like B and C, D is also spread through blood. In order to develop D, you either have to suffer from B or get infected with B at the same time. This happens because D needs the B virus in order to replicate. E has no treatment and there are no vaccines for it.

We strive to provide only quality information, so if there is a specific topic related to hepatitis that you would like us to cover, please contact us at any time.

And again, thank you to those contributing daily to our Hepatitis Website, especially regarding "hepatitis".

If you can't find the Hepatitis information you are looking for?
Try Google Search

Hepatitis C Translating Initiatives for Depression Into Solutions
Conditions: Hepatitis C; Depression Intervention: Other: Depression collaborative care model Sponsor: Department of Veterans Affairs Not yet recruiting - verified June 2010
Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure
Condition: Hepatitis C Intervention: Sponsor: Fundacion IMIM Recruiting - verified November 2009
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C; Oxidative Stress Interventions: Dietary Supplement: silymarin; Dietary Supplement: green tea extract (EGCG) Sponsors: University of North Carolina, Chapel Hill; National Center for Complementary and Alternative Medicine (NCCAM); National Institutes of Health (NIH) Recruiting - verified February 2010
Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients
Condition: Hepatitis C Intervention: Drug: ribavirin pre-treatment Sponsor: University of Roma La Sapienza Recruiting - verified October 2009
Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
Condition: Hepatitis C Intervention: Drug: Pegylated interferon-alfa-2b and ribavirin Sponsor: Region Skane Recruiting - verified January 2010
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection
Condition: Chronic Hepatitis C Intervention: Drug: CT-011 Sponsors: CureTech Ltd; Teva Pharmaceutical Industries Recruiting - verified September 2009
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic; Liver Diseases; Virus Diseases Intervention: Drug: peginterferon alfa-2a and ribavirin Sponsors: University of Ulm; Hoffmann-La Roche Completed - verified January 2010
Efficacy and Safety Study to Evaluate the Effects of Mogroside Sweetener on Viral Load in Treatment (TX) Naive Genotype 1 (GT 1) Subjects With Chronic Hepatitis C (CHC)
Condition: Hepatitis C Intervention: Dietary Supplement: Mogroside sweetener (PureLo) Sponsor: The Geneva Foundation Enrolling by invitation - verified June 2009
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-Responder/Relapsers
Conditions: Chronic Hepatitis C; Genotype 1; Relapse Interventions: Drug: Betaine; Drug: Peginterferon alpha 2a; Drug: Ribavirin Sponsor: University of Nebraska Not yet recruiting - verified April 2009
Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition: Chronic Hepatitis C Interventions: Procedure: Blood sampling of peripheral blood mononuclear cells; Procedure: Blood draw, 20ml peripheral blood mononuclear cells Sponsor: University of Nebraska Terminated - verified January 2010
Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
Conditions: Obesity; Insulin Resistance; Metabolic Syndrome; Hepatitis C Interventions: Drug: Orlistat; Behavioral: Dietary and Lifestyle modification educational sessions Sponsor: University of Pittsburgh Recruiting - verified March 2009
TMC435350-TiDP16-C202: A Study to Assess the Activity of TMC435 on Hepatitis C Virus in Patients Who Have Never Received Treatment for Their Hepatitis C Infection.
Conditions: Hepatitis C, Chronic; Hepatitis C; Infection Intervention: Drug: TMC435 Sponsor: Tibotec Pharmaceuticals, Ireland Completed - verified April 2010
Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
Condition: Hepatitis C Intervention: Sponsor: University of California, San Francisco Recruiting - verified August 2009
A Study Evaluating 24-Week Telaprevir-Based Treatment, or Extended Treatment to 48 Weeks, in Chronic Hepatitis C Patients Who Achieve a Rapid Viral Response
Condition: Hepatitis C Interventions: Drug: telaprevir; Drug: ribavirin; Biological: peginterferon alfa-2a Sponsors: Vertex Pharmaceuticals Incorporated; Tibotec Pharmaceutical Limited Active, not recruiting - verified January 2009
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)(TERMINATED)
Conditions: Hepatitis C, Chronic; Hepacivirus Interventions: Biological: Peginterferon alfa-2b (SCH 54031); Drug: Ribavirin (SCH 18908); Behavioral: Patient assistance program Sponsor: Schering-Plough Terminated - verified July 2008
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic Interventions: Procedure: Liver Biopsy; Drug: Peginterferon & Ribavirin for Hepatitis C; Drug: Pre-treatment Ribavirin Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting - verified March 2010
HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C Interventions: Drug: Oral HDV-Interferon + ribavarin; Drug: Injectable HDV-Interferon + ribavarin Sponsor: Hepasome Pharmaceuticals Active, not recruiting - verified January 2009
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation
Conditions: Hepatitis C Virus Infection; Liver Transplantation Intervention: Procedure: Gradual immunosuppression drug withdrawal. Sponsor: Hospital Clinic of Barcelona Recruiting - verified December 2008
Hepatitis C Treatment and Atherosclerosis
Conditions: Chronic Hepatitis C; Atherosclerosis Intervention: Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting - verified September 2009
Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C Interventions: Drug: pegylated interferon alpha and plus ribavirin; Drug: pegylated interferon alpha and plus ribavirin; Drug: pegylated interferon alpha and plus ribavirin Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital Recruiting - verified February 2007